How to counter the problem of R1 resection in duodenopancreatectomy for pancreatic cancer?
- PMID: 22231631
- DOI: 10.1007/s11605-011-1791-4
How to counter the problem of R1 resection in duodenopancreatectomy for pancreatic cancer?
Abstract
Objective: Although duodenopancreatectomy has been standardized for many years, the pathological examination of the specimen was re-described in the last years. In methodical pathological studies up to 85% had an R1 margin.1,2 These mainly involved the posterior und medial resection margin.3 As a consequence we need to optimize and standardize the pathological workup of the specimen and to extend the surgical resection, where possible without risk for the patient.
Method and result: In an instructive video we show the technique of duodenopancreatectomy with emphasis on the dorsal and medial resection margin. Furthermore we show the standardized pathological workup of the specimen, involving the reporting of all the resection margins.
Conclusion: To accurately determine R1 status at the posterior and medial resection margin, a close collaboration between pathologist and surgeon is crucial. Pathologists do a standardized workup of the resected specimen with staining of the surfaces and systematic analysis of all the resection margins. Surgeons need to extend the resection of the pancreatic head to the superior mesenteric artery by dorsal dissection.
Similar articles
-
An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.HPB (Oxford). 2013 Mar;15(3):218-23. doi: 10.1111/j.1477-2574.2012.00561.x. Epub 2012 Sep 21. HPB (Oxford). 2013. PMID: 23374362 Free PMC article.
-
The advantages of retropancreatic vascular dissection for pancreatic head cancer with portal/superior mesenteric vein invasion: posterior approach pancreatico-duodenectomy technique and the mesopancreas theory.Chirurgia (Bucur). 2012 Sep-Oct;107(5):571-8. Chirurgia (Bucur). 2012. PMID: 23116829
-
Surgical margins for duodenopancreatectomy.Updates Surg. 2016 Sep;68(3):279-285. doi: 10.1007/s13304-016-0404-x. Epub 2016 Oct 25. Updates Surg. 2016. PMID: 27778242
-
[R1 resection for pancreatic carcinoma].Chirurg. 2017 Sep;88(9):764-770. doi: 10.1007/s00104-017-0462-8. Chirurg. 2017. PMID: 28653152 Review. German.
-
Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.Expert Rev Anticancer Ther. 2014 Aug;14(8):919-29. doi: 10.1586/14737140.2014.919860. Epub 2014 May 16. Expert Rev Anticancer Ther. 2014. PMID: 24833085 Review.
Cited by
-
MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.PLoS One. 2016 May 26;11(5):e0155289. doi: 10.1371/journal.pone.0155289. eCollection 2016. PLoS One. 2016. PMID: 27227903 Free PMC article.
-
Radiomics Improves Cancer Screening and Early Detection.Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2556-2567. doi: 10.1158/1055-9965.EPI-20-0075. Epub 2020 Sep 11. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32917666 Free PMC article. Review.
-
Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.J Med Chem. 2012 Nov 26;55(22):9751-62. doi: 10.1021/jm301002f. Epub 2012 Nov 8. J Med Chem. 2012. PMID: 23098072 Free PMC article.
-
Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.J Gastrointest Surg. 2012 Oct;16(10):1875-82. doi: 10.1007/s11605-012-1985-4. Epub 2012 Aug 10. J Gastrointest Surg. 2012. PMID: 22878786
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials